• Issue

    Research and Practice in Thrombosis and Haemostasis: Volume 6, Issue 8

    November 2022
Previous Issue
Export Citation(s)Download PDF(s)

ISSUE INFORMATION

Open Access

Issue Information

  • First Published: 14 November 2022

COMMENTARY

Open Access

Hereditary thrombotic thrombocytopenic purpura: The risk for death at birth

James N. George MD, 
  • First Published: 14 November 2022

ORIGINAL ARTICLES

Open Access

Extended-duration thromboprophylaxis for abdominopelvic surgery: Development and evaluation of a risk-stratified patient decision aid to facilitate shared decision making

Victoria Ivankovic MD,  Kristen McAlpine MD, FRCSC,  Edita Delic BSc, CCRP,  Marc Carrier MSc, MD, FRCPC,  Dawn Stacey RN, PhD, FCAHS, FAAN,  Rebecca C. Auer MSc, MD, FRCSC, 
  • First Published: 14 November 2022
Open Access

Safety and efficacy of long-term emicizumab prophylaxis in hemophilia A with factor VIII inhibitors: A phase 3b, multicenter, single-arm study (STASEY)

Víctor Jiménez-Yuste MD, PhD,  Flora Peyvandi MD,  Robert Klamroth MD,  Giancarlo Castaman MD,  Chandrakala Shanmukhaiah MD, DM,  Savita Rangarajan MD, FRCP, FRCPath,  Jaime García Chavez MD,  Raul Martinez MD,  Gili Kenet MD,  Hazaa Alzahrani MD,  Susan Robson MSc,  Christophe Schmitt PharmD,  Anna Kiialainen PhD,  Oliver Meier PhD,  Margareth Ozelo MD, PhD, 
  • First Published: 14 November 2022
Open Access

Recurrence risk of venous thromboembolism associated with systemic lupus erythematosus: A retrospective cohort study

Soerajja Bhoelan MD,  Jaime Borjas Howard MD,  Vladimir Tichelaar MD, PhD,  Paul van Daele MD, PhD,  Liesbeth Hak MD, PhD,  Alexandre Voskuyl MD, PhD,  Maarten Limper MD, PhD,  Robbert Goekoop MD, PhD,  Onno Teng MD, PhD,  Jelle Vosters MD, PhD,  Marc Bijl MD, PhD,  Els Zirkzee MD, PhD,  Annemarie Schilder MD,  Hein Bernelot Moens MD, PhD,  Karina de Leeuw MD, PhD,  Karina Meijer MD, PhD, 
  • First Published: 14 November 2022
Open Access

Factor eight inhibitor bypassing activity for refractory bleeding in coronary artery bypass grafting: A propensity-matched analysis

Stevan S. Pupovac MD,  Michael A. Catalano MS,  Alan R. Hartman MD,  Pey-Jen Yu MD, 
  • First Published: 02 December 2022
Open Access

Reducing use of coagulation tests in a family medicine practice setting: An implementation study

Fatima Khadadah MBBCh, FRCPC,  Nadia Gabarin MD, FRCPC,  Aziz Jiwajee BComm,  Rosane Nisenbaum PhD,  Hina Hanif BSc,  Paula James MD, FRCPC,  Jonathan Hunchuck PharmD,  Curtis Handford MD, CCFP, MHSc,  Rajesh Girdhari MD, MBA, CCFP (AM),  Michelle Sholzberg MDCM, FRCPC, MSc, 
  • First Published: 09 December 2022
Open Access

Platelet caspase-1 and Bruton tyrosine kinase activation in patients with COVID-19 is associated with disease severity and reversed in vitro by ibrutinib

Livia Claude MSc,  Frédéric Martino MD, MSc,  Patricia Hermand PhD,  Bassel Chahim MD,  Pierre-Marie Roger MD, PhD,  Marie de Bourayne PharmD, PhD,  Yohann Garnier PhD,  Benoit Tressieres MSc,  Yves Colin PhD,  Caroline Le Van Kim PhD,  Marc Romana PhD,  Véronique Baccini PharmD, PhD, 
  • First Published: 09 December 2022
Platelet caspase-1 and Bruton tyrosine kinase activation in patients with COVID-19 is associated with disease severity and reversed in vitro by ibrutinib

Open Access

Impact of different factor VIII inhibitor kinetic profiles on the inhibitor titer quantification using the modified Nijmegen–Bethesda assay

Carolin Ketteler MSc,  Ingrid Hoffmann,  Simon Davidson MPhil,  David Chen MS, MBA,  Andreas Tiede MD, PhD,  Nina Richter PhD, 
  • First Published: 12 December 2022
Impact of different factor VIII inhibitor kinetic profiles on the inhibitor titer quantification using the modified Nijmegen–Bethesda assay

RESEARCH LETTER

Open Access

Cerebral vein thrombosis after ChAdOx1 nCov-19 vaccination: Long-term outcome of four patients

Deepa J. Arachchillage MD, MRCP, FRCPath,  Christina Crossette-Thambiah MRCP,  Namir Asmar MBBS,  Saipriya Ramji MBBS,  Mike Laffan DM, FRCP, FRCPath, 
  • First Published: 16 November 2022
Open Access

Pulmonary embolism–related mortality during the COVID-19 pandemic: Data from the United States

Karlyn A. Martin MD, MS,  Katharine Harrington MPH,  Xiaoning Huang PhD,  Sadiya S. Khan MD, MS, 
  • First Published: 16 November 2022
Open Access

A demonstration of factor XI contributing to hemostasis in the absence of factor XII

Bassem M. Mohammed PhD,  Qiufang Cheng MD,  David Gailani MD, 
  • First Published: 22 November 2022

LETTERS TO THE EDITOR

Open Access

Uncertainties on the prognostic value of admission D-dimer on venous thromboembolism occurrence in patients with COVID-19

Litao Zhang MD,  Zhenlu Zhang PhD, 
  • First Published: 22 November 2022
Open Access

How to use and report data on D-dimer testing in the COVID-19 era?

Litao Zhang MD,  Xiaohui Liu MD,  Zhenlu Zhang PhD, 
  • First Published: 23 November 2022